ESR1 and breast carcinoma: In this study, we used ER+ endocrine sensitive breast cancer cells, MCF7 and T47D, to generate long-term estrogen deprived (LTED) endocrine resistant breast cancer cells that are intrinsically resistant to CDK4/6 inhibitors.